학술논문
A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study)
Document Type
Article
Author
Watanabe, Satoshi; Furuya, Naoki; Nakamura, Atsushi; Shiihara, Jun; Nakachi, Ichiro; Tanaka, Hisashi; Nakao, Mika; Minato, Koichi; Seike, Masahiro; Sasaki, Shinichi; Kisohara, Akira; Takeuchi, Susumu; Honda, Ryoichi; Takamura, Kei; Kagamu, Hiroshi; Yoshimura, Kenichi; Kobayashi, Kunihiko; Kikuchi, Toshiaki
Source
In European Journal of Cancer January 2024 197
Subject
Language
ISSN
0959-8049